UBS’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
$34.5M Buy
307,532
+47,028
+18% +$5.28M 0.03% 535
2014
Q2
$24.7M Buy
260,504
+100,389
+63% +$9.5M 0.02% 614
2014
Q1
$11.3M Sell
160,115
-13,888
-8% -$982K 0.01% 927
2013
Q4
$12.9M Sell
174,003
-72,718
-29% -$5.4M 0.01% 797
2013
Q3
$18.7M Buy
246,721
+4,640
+2% +$352K 0.02% 590
2013
Q2
$19.4M Buy
+242,081
New +$19.4M 0.02% 529